Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8TVF | 8TVF | Langya henipavirus fusion protein in prefusion state | |
| 8TVG | 8TVG | Langya henipavirus postfusion F protein in complex with the 4G5 Fab, local refinement of the viral membrane distal region | |
| 8TVH | A0AA82WPF7 | Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region | |
| 8TVH | 8TVH | Langya henipavirus postfusion F protein in complex with 4G5 Fab, local refinement of the viral membrane proximal region | |
| 8TVI | 8TVI | Langya Virus G glycoprotein (LayV G) with stabilizing mutations | |
| 8TW3 | 8TW3 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
| 8TW3 | H6X1Z0 | hMPV fusion protein complexed with single domain antibodies sdHMPV16 and sdHMPV12 | |
| 8TWO | P13835 | AvrB bound with UDP and RIN4_T166-Rha | |
| 8TWO | 8TWO | AvrB bound with UDP and RIN4_T166-Rha | |
| 8TXM | C3W5S1 | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXM | A0A1D5AKA4 | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXM | 8TXM | Crystal structure of 05.GC.w13.02 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXP | C3W5S1 | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXP | I1ZFF9 | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXP | 8TXP | Crystal structure of 05.GC.w13.01 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TXT | Q5EP31 | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
| 8TXT | A0A6B7HQ27 | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
| 8TXT | 8TXT | Crystal structure of 05.GC.w13.02 Fab in complex with H5 HA from A/Viet Nam/1203/2004(H5N1) | |
| 8TY1 | P00451 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
| 8TY1 | P12263 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
| 8TY1 | 8TY1 | Cryo-EM structure of coagulation factor VIII bound to NB2E9 | |
| 8TY7 | G8EHJ9 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TY7 | I1ZFF9 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TY7 | 8TY7 | Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) | |
| 8TYL | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
| 8TYO | P0DTC2 | Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2 | |
| 8TYP | P09871 | Complement Protease C1s Inhibited by 6-(4-phenylpiperazin-1-yl)pyridine-3-carboximidamide | |
| 8TZO | O00755 | Structure of human Wnt7a bound to WLS and CALR | |
| 8TZO | Q5T9L3 | Structure of human Wnt7a bound to WLS and CALR | |
| 8TZO | P27797 | Structure of human Wnt7a bound to WLS and CALR | |
| 8TZR | P56704 | Structure of human Wnt3a bound to WLS and CALR | |
| 8TZR | Q5T9L3 | Structure of human Wnt3a bound to WLS and CALR | |
| 8TZR | P27797 | Structure of human Wnt3a bound to WLS and CALR | |
| 8TZU | P36334 | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
| 8TZU | 8TZU | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
| 8U01 | B5CXD3 | Crystal Structure of the Glycoside Hydrolase Family 2 TIM Barrel-domain Containing Protein from Phocaeicola plebeius | |
| 8U0T | A0A0N7IQX6 | PRD-0038 RBD bound to Rhinolophus alcyone ACE2 (local refinement) | |
| 8U0T | 8U0T | PRD-0038 RBD bound to Rhinolophus alcyone ACE2 (local refinement) | |
| 8U18 | A0A8H8ULK5 | Cryo-EM structure of murine Thrombopoietin receptor ectodomain in complex with Tpo | |
| 8U18 | Q08351 | Cryo-EM structure of murine Thrombopoietin receptor ectodomain in complex with Tpo | |
| 8U18 | P40226 | Cryo-EM structure of murine Thrombopoietin receptor ectodomain in complex with Tpo | |
| 8U1C | A0A1S7DL21 | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1C | 8U1C | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1D | 8U1D | Cryo-EM structure of vaccine-elicited CD4 binding site antibody DH1285 bound to HIV-1 CH505TFchim.6R.SOSIP.664v4.1 Env Local Refinement | |
| 8U1G | P0DTC2 | Prefusion-stabilized SARS-CoV-2 S2 subunit | |
| 8U1Q | A0A1S7DL21 | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1Q | 8U1Q | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1S | A0A1S7DL21 | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1S | 8U1S | A mechanistic understanding of protective influenza B neuraminidase mAbs at the airway interface | |
| 8U1U | P22362 | Structure of a class A GPCR/agonist complex |
